You just read:

U.S. FDA Expands Indication of INVOKAMET® (canagliflozin/metformin HCl) to Include First-Line Treatment of Adults with Type 2 Diabetes

News provided by

Janssen Pharmaceuticals, Inc.

May 24, 2016, 08:00 ET